查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2037208

全球病毒載體生產服務市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Viral Vector Manufacturing Services Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 232 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球病毒載體生產服務市場規模預計將從2025年的87.6億美元成長至2034年的408.8億美元，2026年至2034年的複合年成長率（CAGR）為18.67%。基因治療和先進生物製藥需求的不斷成長推動了該市場的快速發展。病毒載體是用來遞送遺傳物質以達到治療目的的重要工具。遺傳疾病盛行率的上升和對個人化醫療日益成長的關注正在推動市場成長。為了滿足不斷成長的病毒載體需求，製藥和生技公司擴大將生產服務外包給專業公司。

推動成長的因素包括生物技術的進步和基因治療相關臨床試驗的增加。對擴充性且經濟高效的生產解決方案日益成長的需求，正在促進專業服務的普及。監管機構對創新治療方法的支持以及新基因治療方法的核准，也有助於市場擴張。此外，研發投入的增加正在加速病毒載體技術的發展。

未來，病毒載體生產服務市場預計將在生產技術和產能方面取得顯著進展。各企業將致力於提高效率和降低成本，以滿足不斷成長的市場需求。新一代載體的研發，尤其是安全性和有效性的提升，將進一步推動市場成長。隨著基因療法的不斷發展，對可靠且可擴展的生產服務的需求預計將持續成長。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業格局。

市場動態：對影響市場成長的關鍵促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭動態以及主要參與者所採取的策略。

市場預測：本預測是基於特定預測期內的市場規模和成長模式數據。本節結合歷史趨勢、當前市場狀況和定量分析，揭示未來預期趨勢。

區域分析：本部分全面回顧了主要地理區域的市場表現，確定了高成長領域和區域趨勢，從而更深入地了解區域市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點或專注於特定細分市場的洞察，以更好地支持您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球病毒載體生產服務市場：依類型分類

  • 市場分析、洞察與預測
  • 病毒載體
  • 質體DNA

第5章：全球病毒載體生產服務市場：依產品與服務分類

  • 市場分析、洞察與預測
  • 產品
  • 服務

第6章 全球病毒載體生產服務市場：依工作流程分類

  • 市場分析、洞察與預測
  • 上游工程
  • 下游工藝

第7章 全球病毒載體生產服務市場：依應用領域分類

  • 市場分析、洞察與預測
  • 細胞和基因治療
  • 疫苗研發
  • 調查

第8章：全球病毒載體生產服務市場：依疾病適應症分類

  • 市場分析、洞察與預測
  • 癌症
  • 遺傳性疾病
  • 感染疾病
  • 其他

第9章：全球病毒載體生產服務市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 製藥和生物製藥公司
  • 學術機構和研究機構
  • 其他

第10章 全球病毒載體生產服務市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第11章 競爭格局

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第12章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Thermo Fisher Scientific Inc
    • Lonza Group AG
    • WuXi AppTec Co. Ltd
    • Merck KGaA
    • GenScript Biotech Corporation
    • FUJIFILM Holdings Corporation
    • Catalent Inc
    • Charles River Laboratories International Inc
    • Novartis International AG
    • Sartorius AG
    • Danaher Corporation
    • Oxford Biomedica Plc
    • Precision Biosciences Inc
    • Bluebird Bio Inc
    • VGXI Inc
簡介目錄
Product Code: VMR11213138

The global viral vector manufacturing services market size is expected to reach USD 40.88 Billion in 2034 from USD 8.76 Billion in 2025, growing at a CAGR of 18.67 during 2026-2034.This market is witnessing rapid growth due to the increasing demand for gene therapies and advanced biologics. Viral vectors are essential tools used in the delivery of genetic material for therapeutic purposes. The rising prevalence of genetic disorders and the growing focus on personalized medicine are driving market growth. Pharmaceutical and biotechnology companies are increasingly outsourcing manufacturing services to specialized providers to meet the growing demand for viral vectors.

Growth drivers include advancements in biotechnology and the increasing number of clinical trials for gene therapies. The need for scalable and cost-effective manufacturing solutions is encouraging the adoption of specialized services. Regulatory support for innovative therapies and the approval of new gene-based treatments are also contributing to market expansion. Additionally, the growing investment in research and development is accelerating the development of viral vector technologies.

Looking ahead, the viral vector manufacturing services market is expected to witness significant advancements in production technologies and capacity expansion. Companies are likely to focus on improving efficiency and reducing costs to meet increasing demand. The development of next-generation vectors with enhanced safety and efficacy will further drive market growth. As gene therapy continues to evolve, the demand for reliable and scalable manufacturing services is anticipated to rise.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Type

  • Viral Vectors
  • Plasmid DNA

By Product & Services

  • Product
  • Services

By Workflow

  • Upstream Manufacturing
  • Downstream Manufacturing

By Application

  • Cell and Gene Therapy
  • Vaccine Development
  • Research

By Disease Indication

  • Cancer
  • Generic Disorders
  • Infectious Diseases
  • Others

By End User

  • Pharmaceutical and Biopharmaceutical Companies
  • Academics and Research Institutes
  • Others

COMPANIES PROFILED

  • Thermo Fisher Scientific Inc., Lonza Group AG, WuXi AppTec Co. Ltd., Merck KGaA, GenScript Biotech Corporation, FUJIFILM Holdings Corporation, Catalent Inc., Charles River Laboratories International Inc., Novartis International AG, Sartorius AG, Danaher Corporation, Oxford Biomedica plc, Precision Biosciences Inc., Bluebird Bio Inc., VGXI Inc.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL VIRAL VECTOR MANUFACTURING SERVICES MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Viral Vectors Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Plasmid DNA Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL VIRAL VECTOR MANUFACTURING SERVICES MARKET: BY PRODUCT & SERVICES 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Product & Services
  • 5.2. Product Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL VIRAL VECTOR MANUFACTURING SERVICES MARKET: BY WORKFLOW 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Workflow
  • 6.2. Upstream Manufacturing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Downstream Manufacturing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL VIRAL VECTOR MANUFACTURING SERVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Application
  • 7.2. Cell and Gene Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Vaccine Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Research Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL VIRAL VECTOR MANUFACTURING SERVICES MARKET: BY DISEASE INDICATION 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast Disease Indication
  • 8.2. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Generic Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL VIRAL VECTOR MANUFACTURING SERVICES MARKET: BY END USER 2022-2034 (USD MN)

  • 9.1. Market Analysis, Insights and Forecast End User
  • 9.2. Pharmaceutical and Biopharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 9.3. Academics and Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 9.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL VIRAL VECTOR MANUFACTURING SERVICES MARKET: BY REGION 2022-2034 (USD MN)

  • 10.1. Regional Outlook
  • 10.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 10.2.1 By Type
    • 10.2.2 By Product & Services
    • 10.2.3 By Workflow
    • 10.2.4 By Application
    • 10.2.5 By Disease Indication
    • 10.2.6 By End User
    • 10.2.7 United States
    • 10.2.8 Canada
    • 10.2.9 Mexico
  • 10.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 10.3.1 By Type
    • 10.3.2 By Product & Services
    • 10.3.3 By Workflow
    • 10.3.4 By Application
    • 10.3.5 By Disease Indication
    • 10.3.6 By End User
    • 10.3.7 United Kingdom
    • 10.3.8 France
    • 10.3.9 Germany
    • 10.3.10 Italy
    • 10.3.11 Russia
    • 10.3.12 Rest Of Europe
  • 10.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 10.4.1 By Type
    • 10.4.2 By Product & Services
    • 10.4.3 By Workflow
    • 10.4.4 By Application
    • 10.4.5 By Disease Indication
    • 10.4.6 By End User
    • 10.4.7 India
    • 10.4.8 Japan
    • 10.4.9 South Korea
    • 10.4.10 Australia
    • 10.4.11 South East Asia
    • 10.4.12 Rest Of Asia Pacific
  • 10.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 10.5.1 By Type
    • 10.5.2 By Product & Services
    • 10.5.3 By Workflow
    • 10.5.4 By Application
    • 10.5.5 By Disease Indication
    • 10.5.6 By End User
    • 10.5.7 Brazil
    • 10.5.8 Argentina
    • 10.5.9 Peru
    • 10.5.10 Chile
    • 10.5.11 Rest of Latin America
  • 10.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 10.6.1 By Type
    • 10.6.2 By Product & Services
    • 10.6.3 By Workflow
    • 10.6.4 By Application
    • 10.6.5 By Disease Indication
    • 10.6.6 By End User
    • 10.6.7 Saudi Arabia
    • 10.6.8 UAE
    • 10.6.9 Israel
    • 10.6.10 South Africa
    • 10.6.11 Rest of the Middle East And Africa

Chapter 11. COMPETITIVE LANDSCAPE

  • 11.1. Recent Developments
  • 11.2. Company Categorization
  • 11.3. Supply Chain & Channel Partners (based on availability)
  • 11.4. Market Share & Positioning Analysis (based on availability)
  • 11.5. Vendor Landscape (based on availability)
  • 11.6. Strategy Mapping

Chapter 12. COMPANY PROFILES OF GLOBAL VIRAL VECTOR MANUFACTURING SERVICES INDUSTRY

  • 12.1. Top Companies Market Share Analysis
  • 12.2. Company Profiles
    • 12.2.1 Thermo Fisher Scientific Inc
    • 12.2.2 Lonza Group AG
    • 12.2.3 WuXi AppTec Co. Ltd
    • 12.2.4 Merck KGaA
    • 12.2.5 GenScript Biotech Corporation
    • 12.2.6 FUJIFILM Holdings Corporation
    • 12.2.7 Catalent Inc
    • 12.2.8 Charles River Laboratories International Inc
    • 12.2.9 Novartis International AG
    • 12.2.10 Sartorius AG
    • 12.2.11 Danaher Corporation
    • 12.2.12 Oxford Biomedica Plc
    • 12.2.13 Precision Biosciences Inc
    • 12.2.14 Bluebird Bio Inc
    • 12.2.15 VGXI Inc